C
oronary computed tomography angiography (CTA) has emerged as a powerful method for accurately assessing coronary artery stenosis and characterizing coronary atherosclerosis, providing a wealth of diagnostic and prognostic information. These anatomic measurements, however, do not provide insight into the activity of the disease and fail to depict the biological processes implicated in plaque rupture. 1 Assessment of plaque activity may improve the patient risk prediction provided by CTA. Recently, it was shown that 18 F-sodium fluoride ( 18 F-NaF) positron-emission tomography (PET) imaging, providing an assessment of developing microcalcification within coronary plaque, might provide such an assessment. 2 18 F-NaF PET imaging, however, requires coregistered CTA images for precise anatomic localization of 18 F-NaF within coronary plaques. [2] [3] [4] [5] [6] Increased 18 F-NaF uptake has been observed with hybrid PET/CTA to localize in regions of recent plaque rupture in patients with acute myocardial infarction, as well as in coronary plaques with high-risk features on intravascular ultrasound in patients with stable coronary artery disease. 3 Other PET tracers targeting different aspects of coronary plaque activity are increasingly becoming available. 4 The standard approach used to date for coronary 18 F-NaF PET/CT has several limitations which hamper its practical implementation into meaningful clinical workflow. 5 Studies to date have utilized CTA acquired using hybrid PET/CTA scanner during the same imaging session. [2] [3] [4] [5] [6] [7] [8] [9] [10] This approach, however, does not lend itself to patient selection for imaging based on prior CTA findings. If the 18 F-NaF imaging becomes part of a clinical assessment strategy, it is likely that patients would be selected for 18 F-NaF PET based on the findings of a CTA performed for clinical purposes. 11, 12 Another key limitation of the single-session hybrid PET/CTA protocol is that it may not allow for the use of optimal CT equipment for CTA which may only be available on standalone CT scanners. Finally, the use of hybrid PET/CTA requires multifaceted staff expertise in both PET and coronary CTA during a single session. To address these limitations, we assessed the feasibility of utilizing a previously acquired CTA with a subsequent PET-only coronary scan for the evaluation of coronary 18 F-NaF PET uptake.
METHODS

Study Population
We analyzed scans of patients with stable coronary artery disease who first underwent CTA (CTA1) followed by a hybrid 18 F-NaF PET of the coronary arteries with second CTA (CTA2). We analyzed data from 2 cohorts of patients. Cohort 1 consisted of 20 subjects who underwent CTA 1 and hybrid PET/ CTA on the same scanner within 14 days. Cohort 2 consisted of 25 patients whose initial CTA acquisition was performed on a standalone CT and had hybrid PET/CTA in a median of 17 days (14-37) after CTA 1. All subjects had angiographically proven multivessel coronary artery disease (defined as at least 2 major epicardial vessels with any combination of either >50% luminal stenosis, or previous revascularization). Exclusion criteria included an acute coronary syndrome within the previous 12 months, renal dysfunction (estimated glomerular filtration rate ≤30 mL/min per 1.73 m 2 ), and contraindication to iodinated contrast agents. The study was approved by the investigational review board, and written informed consent was obtained from all subjects.
Image Acquisition and Reconstruction
Initial Coronary CTA Cohort 1 had the CTA1 scan performed on the 128-slice Biograph mCT scanner (Siemens Medical Systems, Erlangen, Germany) during held expiration using the following settings: 330 ms rotation time, 100 or 120 kV (depending on body mass index), 160 to 245 mAs. Cohort 2 underwent a deepinspiration CTA1 on a dual source CT scanner (Definition; Siemens Medical Systems, Erlangen, Germany). The scan parameters were as follows: 330 ms gantry rotation time, reference tube current of 400 mAs per rotation, and a peak tube voltage of 120 kV. Patients in both cohorts received betablockers (orally or intravenously) to achieve a target heart rate <60 bpm and sublingual nitrates. A bolus of 60 to 100 mL of contrast (300-400 mgI/mL; Iomeron) was power injected intravenously at 6 mL/s, after determining the appropriate
CLINICAL PERSPECTIVE
The standard approach used to date for coronary 18 F-NaF positron-emission tomography (PET)/ computed tomography (CT) has several limitations which hamper its practical implementation into meaningful clinical workflow. Studies to date have utilized CT angiography (CTA) acquired using hybrid PET/CTA scanners during a single imaging session. This approach, however, does not lend itself to patient selection for imaging based on prior CTA findings, it may not allow for the use of optimal CT equipment for CTA (which may only be available on standalone CT scanners) and requires multifaceted staff expertise in both PET and coronary CTA during a single session. In this study, we show that utilization of a previously acquired CTA with a subsequent PET-only coronary 18 F-NaF acquisition enables adequate categorization of plaques with respect to the presence of increased tracer activity and accurate quantification of PET uptake. This approach facilitates the selection of high-risk patients for PET-only 18 F-NaF PET imaging, based on results from prior CTA scan. Given the simplicity of the prior CTA and subsequent PET-only acquisition protocol, we think that this approach can facilitate dissemination of 18 F-NaF coronary uptake imaging beyond experienced academic institutions. Kwiecinski F-sodium fluoride was injected intravenously, and patients rested in a quiet environment for 60 minutes. Because emission scanning was followed by CTA during that hour, subjects were administered with beta-blockers. Imaging was performed on 2 different PET/CT scanners 128-slice Biograph mCT, Siemens Medical Systems (cohort 1) and 128-slice Discovery 710 (GE Healthcare, Milwaukee, WI, (cohort 2). In both cohorts, low-dose CT attenuation correction scan (120 kV, 50 mAs, 3 mm slice thickness), a 30-minute single bed position PET acquisition with ECG-gating in list mode, was performed. Image corrections were applied for attenuation, dead time, scatter, and random coincidences. In cohort 1, PET data were reconstructed using a Siemens implementation of iterative reconstruction algorithm (Ultra-HD; with Point Spread function correction and time of flight reconstruction, matrix 256, gaussian filter of 5 mm, and 2 iterations and 21 subsets). In cohort 2, data were reconstructed with GE implementation of iterative reconstruction algorithm (Sharp IR with Point Spread function correction and time of flight reconstruction, matrix 256, gaussian filter of 5 mm, and 4 iterations and 24 subsets). 13 In both cohorts, a second CTA (CTA2) was obtained on the hybrid scanner with patient remaining on the table in the same position as during emission scanning. In cohort 1 (Siemens Biograph mCT), imaging was performed on the same scanner and according to the same protocol as CTA1. In cohort 2 (GE Discovery 710) CTA2 was acquired with rotation time 350ms, tube voltage 120 kV, tube current 150-250 mAs and reconstructed with 0.625 mm thick slices, a 0.625 mm increment, and a medium-soft convolution kernel.
Image Analysis
Cardiac Motion Correction
In addition to assessing diastolic PET data, we also analyzed cardiac motion-corrected 18 F-NaF PET images. This technique compensates for coronary artery motion by aligning all cardiac gates to the reference gate (the one which is used for PET and CTA coregistration-see below). This approach was shown to reduce image noise and improve target to background ratios (TRB).
14 To perform cardiac motion correction in the first step, coronary artery centerlines were extracted from coronary CTA by applying a vessel tracking algorithm based on Bayesian maximal paths using dedicated software (Autoplaque version 2.0, Cedars-Sinai Medical Center). Second, a diffeomorphic mass-preserving image registration algorithm was used to align the gates of PET data to the end-diastolic (reference) gate.
14 As a result, all gates were summed back together providing a motion-free image containing counts from the entire duration of PET acquisition.
Image Registration
Image registration was performed using FusionQuant Software (Cedars-Sinai Medical Center, L.A.). PET and CTA reconstructions were reoriented, fused, and carefully coregistered in all 3 planes (a X-Y-Z translation was performed) as described previously. 8, 9 Key points of reference were the sternum, vertebrae, blood pool in the left, and right ventricle (based on high We fused (orange arrow) the CTA from the first visit (CTA1) with an 18 F-NaF PET from the second visit (PET). The PET/CTA imaging session comprised the acquisition of a low-dose attenuation correction scan (AC) followed by a 30-min long PET registration (PET) and finally the coronary CTA. F-fluoride activity in the blood pool in comparison to the surrounding myocardium) and the great vessels. We fused CTA1 from the first visit with PET and also separately fused CTA2 with PET. Although CTA2 was obtained at the same imaging session as PET on the hybrid scanner, coregistration was performed to account for any possible patient motion between PET and CTA2. Both CTA1 and CTA2 were coregistered to PET in an identical fashion (Figure 1 ). This way, we could compare Boxplots presenting the translational adjustments in 3 axes (x, y, z) made to the PET images to align the 2 datasets for CTA acquired during hybrid PET/ CTA session (hybrid) and for prior-CTA fused with PET-only 18 F-NaF scan (prior CTA). The prior CTA (PET/CTA1) dataset required bigger adjustments than the hybrid-single imaging session (PET/CTA2) dataset (all P<0.01; A). Bland-Altman plots presenting the interobserver variability of the coregistration adjustments of the hybrid (B) and prior CTA (C) datasets. There was no significant difference in the reproducibility of adjustments for hybrid vs prior datasets (P=0.76). Scatter plot presenting the coregistration adjustments made by 2 independent observers of the prior CTA dataset (D). ICC indicates intraclass correlation coefficient.
Kwiecinski et al; Prior CTA for Coronary 18 F-NaF PET Analysis directly a clinical protocol using a CTA scan acquired up to 4 weeks before a PET-only 18 NaF scan, with a standard hybrid 18 NaF-CTA protocol in individual patients. To assess interobserver reproducibility of the CTA and PET registration, both datasets of cohort 1 patients were fused and reoriented by 2 experienced observers (imaging cardiologists) blinded to each other's adjustments.
F-NaF PET Quantification
After registration of CTA1 and CTA2 to the PET, plaque activity was measured by defining 3-dimensional volumes of interest (spheres with a 5 mm radius) around coronary plaques on both the fused PET/CTA2 and PET/CTA1 images. The maximal standard uptake (SUVmax) value was recorded from each coronary segment that had a diameter of at least 2 mm and included coronary atheroma with a >25% stenosis on CTA and had not been stented previously. Background blood pool activity was measured by delimiting a spherical volume of interest (radius 10-15 mm depending on atrium size) in the middle of the left atrium. TBRs were calculated by dividing SUVmax by mean background blood pool activity. To categorize lesions according to PET tracer uptake, we utilized the previously validated methodology. 2, 3 In brief, plaques were considered to have high uptake if they presented with focal tracer uptake which followed the course of the vessel over >1 slice, and their TBR on diastolic imaging was >1.25. Image noise was defined as the mean SD of the blood pool activity. Signal to noise ratio was defined as the plaque SUVmax divided by image noise. To assess interobserver reproducibility of the uptake measurements on the PET/CTA1 datasets, coronary 18 F-NaF activity of cohort 1 patients was assessed by 2 experienced observers (imaging cardiologists) blinded to each other's delineations.
Reproducibility Analysis
Image analysis of PET/CTA1 and PET/CTA2 was performed on diastolic and motion-corrected images. To limit the potential for recall bias between PET/CTA1 and PET/CTA2, PET/CTA1 was anonymized against PET/CTA2, and there was at least a 3-week interval between reading PET/CTA1 and PET/CTA2 images. For each scan, PET registration and regions of interest were saved using the reference CTA, and the same registration position so that the same regions of interest could be measured in the diastolic and motion-corrected images. Reproducibility was defined as the difference in PET SUV max or TBR measured from PET/CTA1 and PET/CTA2 datasets.
Statistical Analysis
Data were tested for normality using Shapiro Wilks test. Continuous variables were expressed as mean ±SD or median (interquartile range) and compared with paired Student t or Wilcoxon signed-rank test where appropriate. We presented all categorical variables as percentages and used the χ 2 test for comparison. We used Bland-Altman plots to visualize reproducibility of measurements. The 95% normal range for differences between sets of SUV and TBR measurements (the limits of agreement) were estimated by multiplying the SD of the mean difference by 1.96. 15 Intraclass correlation coefficients with 95% CIs were calculated for PET/CTA1 versus PET/CTA2 scan variation. The Pitman-Morgan test was used to compare the homogeneity of variance between uptake measurements derived from diastolic gate and motion-corrected datasets. In our per lesion analysis, we assumed independence of lesions within patients. A 2-sided P<0.05 was regarded as statistically significant. Statistical analysis was performed with SPSS software (version 24, SPSS, Inc, Chicago, IL).
RESULTS
A total of 45 patients (age 67.1±6.9 years; 76% males) underwent CTA1 and a subsequent PET/CT with CTA2 at a median of 14 (10, 21) days. All patients had multivessel disease on CTA1 (Table 1) . Detailed study results can be made available to other researchers on request to the corresponding author. The intraclass correlation coefficient for spatial adjustments between 2 observers was 0.92 (95% CI, 0.87-0.95) for PET/CTA2 and 0.99 (95% CI, 0.993-0.997) for PET/CTA1 ( Figure 2D ). There was no fixed or proportional bias between observers with limits of agreement of ±4.5 mm for both the hybrid and the prior CTA dataset (Figure 2 ). Despite the need for larger adjustments of PET/CTA1, there was no significant difference in the reproducibility of adjustments between both datasets (P=0.76).
Image Registration
F-NaF PET Quantification
Twenty-eight (62%) patients had high 18 F-NaF coronary uptake on PET/CTA2. Fifty-eight coronary segments showed high 18 F-NaF uptake (TBR>1.25). The remaining 168 segments with at least a 25% CTA stenosis had PET TBR measurements ≤1.25. On PET/CTA1, all interrogated segments were classified identically as on PET/ CTA2 (according to the 1.25 TBR cutoff; Figure 1 and Figure I in the Data Supplement). 
Diastolic Imaging
Motion Correction
After applying motion correction, the signal to noise ratio improved when compared with diastolic imaging (25.2±11.9 versus 30.8±17.2; P=0.01). On motion- 
Reproducibility of Measurements
On diastolic imaging, the intraclass correlation coefficients for SUVmax and TBR between PET/CTA1 and PET/CTA2 measurements were 0. 
DISCUSSION
In this multivendor and multicenter study, we report how utilizing a previously acquired CTA with a subse- Kwiecinski et al; Prior CTA for Coronary 18 F-NaF PET Analysis quent standalone PET-only coronary scan can be used for the evaluation of coronary 18 F-NaF PET uptake. On a population comprised of patients who underwent repeat CTA studies on the same PET/CT scanner (cohort 1) and a separate subset that had the initial CTA acquired on a solely CT machine (cohort 2), we show that a prior CTA and subsequent PET-only approach enables equivalent categorization of plaques with increased 18 F-NaF activity and accurate quantification of PET uptake. We demonstrate that staged coronary PET and CTA protocols can reliably and reproducibly generate quantitative 18 F-NaF PET coronary images that are enhanced by motion correction.
These findings have important implications for future research and clinical coronary 18 F-NaF imaging. The prior CTA and subsequent PET-only acquisition protocol lends itself to a practical clinical workflow, with the initial CTA providing a basis for selection of patient for the coronary PET study. CTA is growing rapidly in a wide variety of clinical settings. Therefore, CTA will likely be the most common basis for selection of patients who might benefit from assessment of disease activity with coronary PET imaging. In this scenario, the requirement for a second CTA obtained at the time of coronary PET imaging would not be practical or economically feasible and incurs unnecessary additional radiation exposure. In carefully selected populations at high risk of adverse events, 18 F-NaF PET could provide insight into the biology of atherosclerosis and may prove to be of importance in patient management. 16, 17 It has been shown that the presence of vulnerable plaque features predicts acute coronary syndromes, and in the absence of signif- icant stenosis and coronary calcification, the likelihood of adverse events is low. 7, 18 Therefore, the CTA first approach could limit unwarranted 18 F-NaF PET scans in low-risk populations. 5 However, a follow-up standalone 18 F-NaF PET scan could be warranted in individuals who present with a high atherosclerotic plaque burden to differentiate active from burnt out stable disease, or in patients with high-risk plaque features, such as those with positive remodeling, low attenuation components, and the napkin-ring sign on CTA. 6 Importantly, CTA scans acquired on hybrid PET/CT are often of suboptimal quality because of limited CT performance in this configuration. In many PET laboratories, either the PET scanner does not have performance characteristics required for coronary CTA or a standalone CT scanner with better imaging characteristics for coronary CTA is available. Because coronary CTA is strongly dependent on image quality, the most advanced CT scanners should be used for this application. Although the current hybrid PET/CT scanners are at best 128-slice systems, the dedicated CTA equipment can be a 320-slice or dual source (196 slices) setup which can cover the entire heart in 1 gantry rotation , . 19 Furthermore, the scanning protocol for hybrid PET/CTA requires technical staff with expertise in both PET and coronary CTA to be present during a single session. In many centers that offer both PET and CTA scans, the imaging team performing PET studies does not have extensive experience in CTA. Thus, separate technologists with CTA expertise might be required to perform the CTA portion of the PET/CT examination, raising the cost and complexity of the procedure. With the utilization of CTA obtained before the 18 F-NaF PET, such inconvenience would no longer occur. A prior CTA approach to 18 F-NaF PET would also shorten the duration of image acquisition substantially and overall patient radiation exposure by avoiding repetition of the CTA scan.
As expected, we observed that larger registration adjustments were needed to achieve perfect align- Both datasets were motion corrected after registration of CTA to PET. For the hybrid acquisition, the required adjustments were 0.5, 2.5, and 0 mm in the x, y, and z axis, respectively. For prior CTA dataset PET had to be moved by 2.5, 3, and 5 mm in the corresponding axes. Lesions with increased tracer uptake were identified in the left main, lesion target to background ratio (TBR) 1.56 and 1.55 (A and A') and proximal right coronary artery, lesion TBR 1.60 and 1.60 (B and B').
Kwiecinski et al; Prior CTA for Coronary 18 F-NaF PET Analysis A 67-y-old-male with uptake in the distal RCA (yellow arrow) and noncoronary uptake in the inferomedial papillary muscle (red arrow; A). The uptake in the papillary muscle is more pronounced than in the coronary plaque (B). In the transverse plane, the extra coronary foci of uptake can be easily seen (red arrows; C) and have higher activity than the RCA plaques (yellow arrows; D). Taking advantage of the computed tomography angiography (CTA), which was used for anatomic reference, careful inspection of the dataset revealed an area of low attenuation within the inferior left ventricular (LV) wall and the posteromedial papillary muscle (red arrow) as compared to the LV anteroseptum (blue arrow; E and F). Such low attenuation can be seen in infarcted myocardium, which might, in the process of healing, develop foci of microcalcification (which attract 18 F-NaF). Without the reference of a CTA, the foci of pronounced 18 F-NaF uptake could potentially be erroneously attributed to plaques in the posterior descending artery or the posterior left ventricular artery. Because of the findings on the positron-emission (Continued ) Kwiecinski et al; Prior CTA for Coronary 18 F-NaF PET Analysis ment of CT acquired during a different imaging session from the PET compared with hybrid PET/CTA acquisition. However, with the image registration approach utilized, all images could be successfully registered and analyzed. Moreover, it is important to realize that even the hybrid PET/CTA approach requires substantial modification of image alignment for adequate coregistration ( Figure 2 ). This is largely because of gross patient motion which occurs during the pause between PET and CTA acquisitions and differences in respiratory patterns. Indeed, no hybrid PET/CTA scan in this study was perfectly coregistered at baseline with each requiring such spatial adjustments.
In patients with multiple foci of increased 18 F-NaF activity, achieving perfect registration of all lesions can be challenging. In our study, in such cases, we observed a maximal misalignment of 5 mm (from the center of vessel on CTA to the center of the hot spot on PET. Importantly misalignment was similarly common on both single visit acquisitions and when using prior CTA data. To offset for such issues, for the SUVmax measurements, we used a spherical volume of interest (radius 5 mm) which encompasses the plaque in question (as seen on the CTA) and its immediate surroundings. As a result, in our study misregistration of 2 to 4 mm which can easily occur ( Figure 2B and 2C) had no adverse impact on the accuracy of the uptake measurement as shown on the scatterplots with interobserver variability of SUVmax and TBR measurements ( Figure 3A and 3B) .
The sensitivity of SUVmax measurements to the accuracy of the registration varies from patient to patient and depends on the anatomy. In an ideal scenario (ie, when uptake is only present within coronary arteries) since the volumes of interest utilized have a radius of 5 mm misregistration of up to ≈5 mm will not have an impact. However, in patients with multiple noncoronary uptake foci within that distance from the actual coronary lesions, such misregistration will potentially lead to false positive findings. For instance, when assessing 18 F-NaF activity in the left main or mid left anterior descending artery, special care should be taken to avoid assigning uptake originating from the ascending aorta and main pulmonary artery to the coronaries. Likewise, extracoronary foci of uptake (in patients who suffered from pericardial, aortic, or mitral disease which resulted in calcification outside of coronary arteries) need to be distinguished. Without anatomic reference provided by CTA, accurate quantification of uptake is impossible as increased tracer activity of noncoronary microcalcifications can be erroneously classified (Figure 7) .
Finally, we have demonstrated that by applying correction for coronary artery motion, the reproducibility of such PET-only measurements with prior CTA is significantly improved. In fact, our limits of agreement between PET/CTA1 and PET/CTA2 are comparable to the interobserver repeatability for uptake measurements in the same scan as shown by Dweck et al. 2 The improved PET/CTA2-PET/CTA1 reproducibility with motion correction is likely because of the higher signal to noise in the motion-corrected PET images. 20 
Study Limitations
There are several limitations to our work. Our motion correction method compensated only for cardiac motion; nevertheless, we have been able to demonstrate the utility of this technique in reducing the variation of 18 F-NaF PET quantification with prior CTA. In this study, we have not performed any quality control to identify any gross patient motion during the 30-minute-long emission scan. Although the significance of such motion during acquisition has not been explored for coronary PET imaging, it is likely that it has a detrimental effect on image quality and hence should be addressed in future studies. It might be speculated that gross patient motion correction would make the coregistration of PET and CTA more straightforward as borders between high and low update areas could be better defined. Currently, the PET-CT coregistration was performed manually with translations made in the x, y, and z axis and no rotations between datasets. It is likely that automatization of this process could decrease the time and expertise required for image analysis and translate into rapid dissemination of coronary 18 F-NaF PET imaging beyond highly experienced academic centers. Nevertheless, in this study, despite the manual registration of CTA, we were already able to demonstrate excellent reproducibility of quantification 18 F-NaF PET with separately obtained CTA.
Conclusions
Staged coronary PET and CTA protocols can reliably and reproducibly generate quantitative 18 F-NaF PET coronary images. The reproducibility of such results is enhanced by cardiac motion correction of PET data. This approach may enable a practical method for the selection of Figure 7 Continued. tomography (PET) study, the patient underwent cardiac magnetic resonance imaging which revealed scarring of the inferior wall and posteromedial papillary muscle (area of delayed enhancement [white] as opposed to the remote myocardium [black]; G). Although uptake situated within the myocardium is a rare finding, the same patient showed noncoronary 18 F-NaF activity in the aorta, which without anatomic reference could be easily attributed to one of the left coronary proximal plaques (H). Yellow arrows indicate coronary plaque uptake (in the distal RCA and proximal LAD). The red arrow highlights the infarcted posteromedial papillary muscle. The purple arrow indicates increased PET tracer activity in the ascending aorta, and the blue arrow highlights uptake immediately adjacent to the left coronary cusp of the aortic valve. LAD indicates left anterior descending coronary artery; and RCA, right coronary artery.
